Invasive fungal disease in humans: are we aware of the real impact?
Open Access
- 1 January 2020
- journal article
- research article
- Published by FapUNIFESP (SciELO) in Memórias do Instituto Oswaldo Cruz
Abstract
In this perspective article, the main risk factors of people to develop IFD are summarised, to aid recognising the impact of fungi on human health, an issue often underestimated and underappreciated. Considering that IFD are often disregarded during routine hospital care, it is very important to emphasise to microbiologists, diagnostic laboratory staff and clinicians, that not only the number but the diversity of patients at-risk for IFD are continuously rising, with mortality rates than remain unacceptably high.3 Additionally, most fungal infections are not reportable diseases, thus reliable information on local and global prevalence is not available. This review recalls the updated definition of IFD, collates recent epidemiological data and describes, in order of frequency, the most susceptible groups of people to acquire an IFD, namely those who undergo medical interventions, people with immunosuppression induced either by the treatment of an associated illnesses or by an underlying disease, people with bacterial or viral co-infections and immunocompetent individuals who acquire an IFD by environmental exposure.Keywords
This publication has 73 references indexed in Scilit:
- Hidden Killers: Human Fungal InfectionsScience Translational Medicine, 2012
- The Index Case for the Fungal Meningitis Outbreak in the United StatesThe New England Journal of Medicine, 2012
- Fungal Biofilm ResistanceInternational Journal of Microbiology, 2012
- Epidemiology and Clinical Manifestations of MucormycosisClinical Infectious Diseases, 2012
- Pathogenesis of MucormycosisClinical Infectious Diseases, 2012
- Antifungal, Cytotoxic, and Immunomodulatory Properties of Tea Tree Oil and Its Derivative Components: Potential Role in Management of Oral Candidosis in Cancer PatientsFrontiers in Microbiology, 2012
- Cryptococcal immune reconstitution inflammatory syndrome in HIV-1-infected individuals: proposed clinical case definitionsThe Lancet Infectious Diseases, 2010
- Cost‐Effectiveness of Serum Cryptococcal Antigen Screening to Prevent Deaths among HIV‐Infected Persons with a CD4+Cell Count ⩽100 Cells/μL Who Start HIV Therapy in Resource‐Limited SettingsClinical Infectious Diseases, 2010
- Epidemiology and Outcome of Invasive Fungal Infection in Adult Hematopoietic Stem Cell Transplant Recipients: Analysis of Multicenter Prospective Antifungal Therapy (PATH) Alliance RegistryClinical Infectious Diseases, 2009
- Penicillium marneffeiInfection and Recent Advances in the Epidemiology and Molecular Biology AspectsClinical Microbiology Reviews, 2006